7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ENDRA Life Sciences Inc
(NASDAQ:NDRA) 

NDRA stock logo

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring...

Founded: 2008
Full Time Employees: 15
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends
ENDRA Life Sciences Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 077.51155.02232.53310.03387.54465.05542.56
ENDRA Life Sciences Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 0509.951,019.891,529.842,039.782,549.733,059.673,569.62
ENDRA Life Sciences Op Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -4.42-3.79-3.15-2.52-1.89-1.26-0.630Milllion
ENDRA Life Sciences Free Cashflow Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -4.49-3.85-3.2-2.56-1.92-1.28-0.640Milllion
ENDRA Life Sciences Cash Per Share ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 00.240.480.720.971.211.451.69Milllion
ENDRA Life Sciences (GAAP) P/E ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 -0.95-0.81-0.68-0.54-0.41-0.27-0.140
ENDRA Life Sciences P/B ratio ttm
202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 00.310.620.931.231.541.852.16
No extra charts and metrics for this ticker.